243 related articles for article (PubMed ID: 31599679)
1. Heritable Genome Editing: Who Speaks for "Future" Children?
Knoppers BM; Kleiderman E
CRISPR J; 2019 Oct; 2(5):285-292. PubMed ID: 31599679
[TBL] [Abstract][Full Text] [Related]
2. Heritable Genome Editing and the Downsides of a Global Moratorium.
Macintosh KL
CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680
[TBL] [Abstract][Full Text] [Related]
3. The Daunting Economics of Therapeutic Genome Editing.
Wilson RC; Carroll D
CRISPR J; 2019 Oct; 2(5):280-284. PubMed ID: 31599686
[TBL] [Abstract][Full Text] [Related]
4. Human Germline Genome Editing: An Assessment.
Greely HT
CRISPR J; 2019 Oct; 2(5):253-265. PubMed ID: 31599681
[TBL] [Abstract][Full Text] [Related]
5. The Ethics of Heritable Genome Editing: New Considerations in a Controversial Area.
Adashi EY; Cohen IG
JAMA; 2018 Dec; 320(24):2531-2532. PubMed ID: 30508029
[No Abstract] [Full Text] [Related]
6. Walk the Line: Debating a Germline Editing Moratorium.
Davies K
CRISPR J; 2019 Apr; 2():74-76. PubMed ID: 30998090
[No Abstract] [Full Text] [Related]
7. Ethics of Human Genome Editing.
Coller BS
Annu Rev Med; 2019 Jan; 70():289-305. PubMed ID: 30691366
[TBL] [Abstract][Full Text] [Related]
8. An Exclusive Interview With CRISPR.
McConnell SC
AMA J Ethics; 2019 Dec; 21(12):E1079-1088. PubMed ID: 31876473
[TBL] [Abstract][Full Text] [Related]
9. The ethics of creating genetically modified children using genome editing.
Ishii T
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
[TBL] [Abstract][Full Text] [Related]
10. The role of scientific self-regulation for the control of genome editing in the human germline: The lessons from the Asilomar and the Napa meetings show how self-regulation and public deliberation can lead to regulation of new biotechnologies.
Gregorowius D; Biller-Andorno N; Deplazes-Zemp A
EMBO Rep; 2017 Mar; 18(3):355-358. PubMed ID: 28219901
[TBL] [Abstract][Full Text] [Related]
11. Ethical issues of CRISPR technology and gene editing through the lens of solidarity.
Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R;
Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154
[TBL] [Abstract][Full Text] [Related]
12. The illusion of control in germline-engineering policy.
König H
Nat Biotechnol; 2017 Jun; 35(6):502-506. PubMed ID: 28591117
[No Abstract] [Full Text] [Related]
13. Safety of Germline Genome Editing for Genetically Related "Future" Children as Perceived by Parents.
Ishii T; Beriain IM
CRISPR J; 2019 Dec; 2(6):370-375. PubMed ID: 31746634
[TBL] [Abstract][Full Text] [Related]
14. Communicating Biotech Advances: Fiction versus Reality.
Małyska A; Bolla R; Twardowski T
Trends Biotechnol; 2018 Feb; 36(2):121-123. PubMed ID: 29174176
[TBL] [Abstract][Full Text] [Related]
15. The New RNA-Editing Era - Ethical Considerations.
Gold A; Levanon EY; Eisenberg E
Trends Genet; 2021 Aug; 37(8):685-687. PubMed ID: 33975753
[TBL] [Abstract][Full Text] [Related]
16. [The Washington summit: orange light for genome editing?].
Jordan B
Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181
[TBL] [Abstract][Full Text] [Related]
17. Why Include the Public in Genome Editing Governance Deliberation?
Blasimme A
AMA J Ethics; 2019 Dec; 21(12):E1065-1070. PubMed ID: 31876471
[TBL] [Abstract][Full Text] [Related]
18. Editor's comment on "CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein".
Hohmann S
Mol Genet Genomics; 2017 Jun; 292(3):535-536. PubMed ID: 28251316
[No Abstract] [Full Text] [Related]
19. Procreative Non-Maleficence: A South African Human Rights Perspective on Heritable Human Genome Editing.
Thaldar D; Shozi B
CRISPR J; 2020 Feb; 3(1):32-36. PubMed ID: 32091250
[TBL] [Abstract][Full Text] [Related]
20. Democratic Governance of Human Germline Genome Editing.
Jasanoff S; Hurlbut JB; Saha K
CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
